Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

by Hans-Georg Wirsching, Michael Weller, Stefan Balabanov, Patrick Roth
Published 2021-06-01

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma

by Hans-Georg Wirsching, Manuela Silginer, Elisa Ventura, Will Macnair, Isabel Burghardt, Manfred Claassen, Silvia Gatti, Jürgen Wichmann, Claus Riemer, Hannah Schneider, Michael Weller
Published 2021-03-01

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery

by Patrick J. Cimino, Michael Zager, Lisa McFerrin, Hans-Georg Wirsching, Hamid Bolouri, Bettina Hentschel, Andreas von Deimling, David Jones, Guido Reifenberger, Michael Weller, Eric C. Holland
Published 2017-05-01

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial

by Alex Vils, Marta Bogowicz, Stephanie Tanadini-Lang, Diem Vuong, Natalia Saltybaeva, Johannes Kraft, Hans-Georg Wirsching, Dorothee Gramatzki, Wolfgang Wick, Elisabeth Rushing, Guido Reifenberger, Matthias Guckenberger, Michael Weller, Nicolaus Andratschke
Published 2021-04-01